IL-17E

IL-17E

IL-17E 詳細

Molecule Name
Interleukin-25
分子の別称
IL-17E,IL-25,Interleukin-25
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
IL17E,IL-25,IL-17E,Interleukin-17E,Interleukin 17E,Interleukin 25
バックグランド
Interleukin 25 (IL25) is also known as Interleukin-17E (IL-17E), is a distinct member of the IL17 cytokine family comprised of at least six members sharing a conserved cysteine-knot structure but divergent at the N-terminus. IL-25 is secreted by type 2 helper T cells (Th2) and mast cells. IL25 can induce NF-κB activation, and stimulate the production of IL8. Both this cytokine and IL17B are ligands for the cytokine receptor IL17RB. IL-25 induces the production of other cytokines, including IL-4, IL-5 and IL-13 in multiple tissues, which stimulate the expansion of eosinophils. This cytokine is an important molecule controlling immunity of the gut and has been implicated in chronic inflammation associated with the gastrointestinal tract. IL-25 can kill some types of breast cancer cells.

IL-17E 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
XKH-001(Xinkanghe Biomedical)XKH-001Phase 2 ClinicalBeijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd
Allergic asthma; Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Inflammation; Pulmonary Disease, Chronic Obstructive
詳細